Mercé Guarro, MD, discusses the results from a study evaluating alternatives to monofocal IOLs for patients with early well-controlled primary open-angle glaucoma. The study assessed visual outcomes including contrast sensitivity after implantation with AcrySof IQ Vivity non-diffractive EDOF IOL in patients with bilateral cataracts and mild primary open-angle glaucoma.